Podcast 4
Treatment options for AATD-associated liver disease and current unmet needs
Episode 4. Pavel Strnad and Jeffrey Teckman discuss treatment approaches for people with alpha-1 antitrypsin deficiency, highlighting the role of patient education and routine monitoring. They review current therapies and look ahead to future treatment options, concluding with a discussion on the current unmet needs still facing people with alpha-1 antitrypsin deficiency.
Sponsorship statement
Developed independently by EPG Health, which received educational funding from Takeda, awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MEDTHORITY. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.